现代中药集团(01643.HK) 发盈警,与上年度净溢利4,880万人民币相比,预计2024年度亏损介乎800万至1,200万人民币。预期亏损主要因2024年2月至5月期间因制剂车间进行修缮工程引致之暂时停产及受国家新政策影响以及活跃客户数量下降导致收益减少;及拆除制剂车间导致的物业、厂房及设备处置损失。(de/d)(港股报价延迟最少十五分钟。)
公布日期 | 派息事项 | 派息内容 |
---|---|---|
2024/08/22 | 中期业绩 | 无派息 |
2024/03/22 | 末期业绩 | 无派息 |
2023/08/28 | 中期业绩 | 无派息 |
2023/03/23 | 末期业绩 | 无派息 |
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.